Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial

Journal of the American College of Cardiology

Volumn 57, Issue 17, 2011, Pages 1778-1783

  Yeung, Alan C ^a   Leon, Martin B ^c   Jain, Ash ^b   Tolleson, Thaddeus R ^d   Spriggs, Douglas J ^e   Mc Laurin, Brent T ^f   Popma, Jeffrey J ^g   Fitzgerald, Peter J ^a   Cutlip, Donald E ^g   Massaro, Joseph M ^h   Mauri, Laura ⁱ  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington Hospital   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d Trinity Mother Francis Health System   (United States)

^e Morton Plant Hospital   (United States)

^f Anderson Medical Center   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

coronary artery disease; drug eluting stent; revascularization; zotarolimus

Indexed keywords

ZOTAROLIMUS;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; DRUG SAFETY; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; STENT THROMBOSIS; UNITED STATES;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME; UNITED STATES;

EID: 79955056445     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.03.005     Document Type: Article

References (14)

1. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
2. L. Mauri, J.M. Massaro, and S. Jiang Long-term clinical outcomes with zotarolimus-eluting versus bare-metal stents J Am Coll Cardiol Intv 3 2010 1240 1249
3. J.M. Stolker, K.F. Kennedy, and J.B. Lindsey Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry Circ Cardiovasc Interv 3 2010 327 334
4. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
5. K. Udipi, M. Chen, and P. Cheng Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent J Biomed Mater Res A 85 2008 1064 1071 (Pubitemid 351717975)
6. L. Mauri, M.B. Leon, A.C. Yeung, M. Negoita, M.J. Keyes, and J.M. Massaro Rationale and Design of the Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries (the RESOLUTE US clinical trial) Am Heart J 2011 In press
7. I. Meredith, S. Worthley, and R. Whitbourn Clinical and angiographic results with the next-generation Resolute stent system: a prospective, multicenter, first-in-human trial J Am Coll Cardiol Intv 2 2009 977 985
8. J. Fajadet, W. Wijns, G.J. Laarman ENDEAVOR II Investigators Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
9. M. Leon, L. Mauri, J.J. Popma ENDEAVOR IV Investigators A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12-month outcomes from the ENDEAVOR IV Trial J Am Coll Cardiol 55 2010 543 554
10. H.P. Schultheiss, E. Grube, K.H. Kuck ENDEAVOR II Investigators Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry EuroIntervention 3 2007 76 81
11. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
12. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
13. D.E. Cutlip, D.S. Baim, and K.K. Ho Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971 (Pubitemid 32322224)
14. P. Widimsky, J.A. Belardi, and F.-J. Neumann TCT-282: one year outcomes of patients with Resolute zotarolimus-eluting stent: results of the RESOLUTE International Registry (abstr) J Am Coll Cardiol 56 2010 B65